VMP 35368711000001104

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Clarithromycin 125mg/5ml oral suspension
BNF code 0501050B0AAABAB
Virtual Therapeutic Moiety Clarithromycin
Date identifier became valid 18 Apr 2018
Previous product identifier 324240004
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 5.000
Unit dose form units ml
Unit dose unit of measure spoonful
Virtual Product Ingredient
Ingredient Clarithromycin
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 25.000
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route suspension.oral
Dose Form
Formulation Oral suspension
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Clarithromycin 125mg/5ml oral suspension (A A H Pharmaceuticals Ltd)
Clarithromycin 125mg/5ml oral suspension (Accord-UK Ltd)
Clarithromycin 125mg/5ml oral suspension (Alliance Healthcare (Distribution) Ltd)
Clarithromycin 125mg/5ml oral suspension (Almus Pharmaceuticals Ltd)
Clarithromycin 125mg/5ml oral suspension (Medihealth (Northern) Ltd)
Clarithromycin 125mg/5ml oral suspension (Phoenix Healthcare Distribution Ltd)
Clarithromycin 125mg/5ml oral suspension (Sandoz Ltd)
Clarithromycin 125mg/5ml oral suspension (Sigma Pharmaceuticals Plc)
Clarithromycin 125mg/5ml oral suspension (Sun Pharmaceutical Industries Europe B.V.)
Virtual Medicinal Product Packs
Clarithromycin 125mg/5ml oral suspension 100 ml
Clarithromycin 125mg/5ml oral suspension 70 ml

dm+d data retrieved from TRUD: release NHSBSA_4.2.0_20240415000001, imported on 15th April 2024 at 05:09:22.

Feedback